Broadwood Capital Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Broadwood Capital Inc
CRD #159286
SEC #801-73853
CIK #0001278387
AUM 1,711.4 M (2026-03-31)
Employees 6 (83% Investors, 0% Brokers)
Fees
Minimum
Phone212-508-5735
Address156 West 56th Street
New York, NY 10019
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
19001520114076038002010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
Item 5. Fees and Compensation

Asset-Based Compensation

Each investor in BPLP is charged a management fee based on the value of such investor’s capital account
at an annual rate of 1% per annum (the “Management Fee”), as described in the Partnership’s Confidential
Private Placement Memorandum. The Management Fee is charged in an amount equal to one quarter of
1% (0.25%) each quarter in arrears.

If the investment management agreement between BPLP and the Adviser is terminated during a quarter,
the Management Fee will be calculated as of the termination date and prorated for the number of days
during the quarter in which the investment management arrangement was in effect.

The Management Fee may be reduced or waived at the discretion of the Adviser, as described in the
Partnership’s Confidential Private Placement Memorandum.

Incentive-Based Compensation

The Adviser also receives a quarterly incentive allocation (“Quarterly Incentive Allocation”) equal to 20% of
the net capital appreciation (both realized and unrealized) of the assets of the Partnership, subject to a
“high water mark” calculation.

The Quarterly Incentive Allocation may be reduced or waived at the discretion of the Adviser, as described
in the Partnership’s Confidential Private Placement Memorandum.

Fixed Fee

The Non-Discretionary Advisory Account pays the Adviser a quarterly fee of $75,000 (the “Fixed Fee”).
The Fixed Fee is paid in advance. If the investment advisory agreement between the Non-Discretionary
Advisory Account and the Adviser is terminated during the quarter, the Fixed Fee will be prorated for the
number of days during the quarter in which the investment advisory agreement was in effect. The Adviser
does not deduct the Fixed Fee from the Non-Discretionary Advisory Account. Rather, the Adviser bills the
Non-Discretionary Advisory Account.

The Fixed Fee is negotiated with the Non-Discretionary Advisory Account.

Operational Expenses

In addition to paying the Management Fee and the Quarterly Incentive Allocation, the Partnership will be
responsible for all of the ordinary and necessary expenses of its operation including, without limitation,
brokerage commissions, insurance premiums, legal and auditing expenses, consultant and other service
provider expenses, and similar ongoing operational expenses. Please refer to Item 12 of this Firm Brochure
for a discussion of the Adviser’s brokerage practices. The Partnership assets may be invested in money
market mutual funds, ETFs or other registered investment companies. In these cases, the Partnership will
bear its pro rata share of the investment management fee and other fees of these investment funds, which
are in addition to the Management Fee paid to the Adviser. The Adviser guarantees that the total expenses
of the Partnership for any fiscal year, exclusive of the Management Fee, taxes, interest, brokerage fees
and any extraordinary non-recurring expenses (other than organizational and syndication expenses),
including litigation affecting the Partnership, will not exceed, and the Adviser undertakes to refund to the
Partnership any amount by which such expenses will exceed, one percent (1%) of the Partnership's annual
average net assets, such average net assets to be computed by averaging the net assets as of the end of
each fiscal quarter.

All expenses of the Non-Discretionary Advisory Account (with the exception of services of the Adviser which
shall be rendered at the Adviser’s own expense), including, but not limited to expenses relating to the
execution of investments, shall be paid by the Non-Discretionary Advisory Account.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
Item 7. Types of Clients

The Adviser’s clients consist of the Partnership and the Non-Discretionary Advisory Account, each of which
are private investment funds. The Adviser, however, is not precluded from advising types of clients that
are not listed above.

Under the terms of BPLP’s Limited Partnership Agreement, the minimum initial investment for BPLP is
$250,000, subject to waiver at the discretion of the Adviser. In recent years, the Partnership generally has
accepted initial investments when there is a commitment to invest at least $1,000,000.

The Adviser does not anticipate accepting any other clients in addition to BPLP and the Non-Discretionary
Advisory Account.
Sector Form 13F Holdings Value ($B)
Hansen Natural Corp 0.6
Staar Surgical Co 0.3
Taser International Inc 0.3
Biotime Inc 0.1
Oncocyte Corp 0.0
 
 
 
 
 
 
Holdings by Sector ($B)
3.02.41.81.20.60.02011201620212027
Type Form D Funds Date Sold AUM
HF Broadwood Partners LP [2012-02-14] 109.6 M 1,711.4 M
Filed 2025-08-05 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 1,711.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 1 1,711.4
By Discretionary
Discretionary 1 1,711.4
Non-Discretionary 0 0.0
Total 1 1,711.4
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 1,711.4
Total 1 1,711.4
Form D Directors Role # Filings # Firms 2011 - 2026
Neal Bradsher Executive Officer 7 2
Broadwood Capital Inc Executive Officer 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001278387]
3 [0001278387]
4 [0001278387]
Firm Profile (Form ADV)
Discretionary AUM$0.4B
Clients1
ServesInstitutional
Fund TypesHedge Fund
Form 3/4/5 Subject 2011 - 2026
Bradsher Neal C
Broadwood Partners LP
Oncocyte Corp
Broadwood Capital Inc
Staar Surgical Co
Biotime Inc
Asterias Biotherapeutics Inc
Comarco Inc
Questcor Pharmaceuticals Inc
Palomar Medical Technologies LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Staar Surgical Co STAA
Common Stock
2026-03-13 Buy 316,017 $18.62 5,884,237
Staar Surgical Co STAA
Common Stock
2026-03-13 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2026-03-12 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2026-03-12 Buy 299,432 $18.12 5,425,708
Staar Surgical Co STAA
Common Stock
2026-03-11 Buy 54,764 $17.52 959,465
Staar Surgical Co STAA
Common Stock
2026-03-11 Buy 0 $0.00
Oncocyte Corp IMDX
Common Stock, no par value
2026-02-10 Buy 0 $0.00
Oncocyte Corp IMDX
Common Stock, no par value
2026-02-10 Buy 521,739 $5.75 2,999,999
Staar Surgical Co STAA
Common Stock
2026-01-09 Buy 27,485 $22.05 606,044
Staar Surgical Co STAA
Common Stock
2026-01-09 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2026-01-08 Buy 3,240 $21.94 71,086
Staar Surgical Co STAA
Common Stock
2026-01-08 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2026-01-07 Buy 66,467 $22.00 1,462,274
Staar Surgical Co STAA
Common Stock
2026-01-07 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2026-01-06 Buy 150,000 $22.38 3,357,000
Staar Surgical Co STAA
Common Stock
2026-01-06 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2026-01-06 Buy 186,946 $21.01 3,927,735
Staar Surgical Co STAA
Common Stock
2026-01-06 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2025-11-21 Buy 0 $0.00
Staar Surgical Co STAA
Common Stock
2025-11-21 Buy 797,486 $27.86 22,217,960
showing 20 of 200 most recent transactions
Comparable Firms State AUM
Caius Capital LLP
1,751.0 M
Amity Ventures LLC
CA 1,737.5 M
Commonwealth Credit Advisors LLC
FL 1,730.6 M
Engine Capital Management LP
NY 1,725.5 M
RK Capital Management LLC
FL 1,719.0 M
North Peak Capital Management LLC
NY 1,703.0 M
Prescott General Partners LLC
FL 1,694.9 M
Parsifal Capital Management LP
CT 1,694.4 M
Affinity Asset Advisors LLC
NY 1,691.1 M
ADAR1 Capital Management LLC
TX 1,675.1 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com